Loading insider details...
Beta
Latest Form 4 (Oct 15, 2026): Sale of 1,844 CUE shares, $51.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Cue Biopharma, Inc. (CUE) | Sale | 1,844 | $51.7K |
| Aug 17, 2026 | Cue Biopharma, Inc. (CUE) | Exercise/Conversion | 18,196 | n/a |
| Jul 10, 2026 | Cue Biopharma, Inc. (CUE) | Grant/Award | 54,589 | n/a |
| Jun 12, 2026 | Biomea Fusion, Inc. (BMEA) | Grant/Award | 196,299 | n/a |
| Jun 13, 2025 | Biomea Fusion, Inc. (BMEA) | Grant/Award | 91,970 | n/a |
| Jun 13, 2024 | Biomea Fusion, Inc. (BMEA) | Grant/Award | 51,025 | n/a |
| Apr 29, 2024 | Vaxxinity, Inc. (VAXX) | Grant/Award | 425,000 | n/a |
| Jun 16, 2023 | Biomea Fusion, Inc. (BMEA) | Grant/Award | 6,989 | n/a |
| Jan 20, 2023 | Instil Bio, Inc. (TIL) | Grant/Award | 415,000 | n/a |
| Jun 24, 2022 | Biomea Fusion, Inc. (BMEA) | Grant/Award | 23,867 | n/a |